Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotic Lactobacillus reuteri for bowel preparation in children undergoing colonoscopy
IRCT20220413054526N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jun 2022
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of lactobacillus reuteri in eosinophilic gastritis (EG) and eosinophilic enteritis (EoN), sponsored by Tehran University of Medical Sciences. Started Jun 2022; status: completed.
02
Drugs
lactobacillus reuteri
03
Conditions
eosinophilic gastritis (EG)eosinophilic enteritis (EoN)
Beyond the preview
Go deeper on IRCT20220413054526N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220413054526N1.